Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
EVO · against 1,335 other Healthcare companies
Ranked #929 of 1,336 · scores higher than 30% of peers
Bars: peers in each 10-point band of the profitability score134 peers with a profitability score of 30–39, including EVO · Click a bar to see the companies
Mainly because of its operating margin, return on assets and return on invested capital, which are weaker than most Healthcare peers.
| Metric | EVO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | -6.6% | 4.7% | 28% | 33% | |
| Operating marginHigher is better · 1,251 reported | -7.1% | 7.1% | 27% | 33% | |
| Return on assetsHigher is better · 1,315 reported | -6.0% | 1.7% | 28% | 33% | |
| Return on equityHigher is better · 1,252 reported | -26.1% | 3.2% | 24% | Context only | |
| Gross marginHigher is better · 1,394 reported | 8.5% | 45.9% | 18% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 929 | 40.1B JPY (≈$273M) | 30 | 45 | |
| 929 | 2.4B HKD (≈$310M) | 30 | 52 | |
| 929 | 327M USD | 30 | 40 | |
| 929 | 2.8B USD | 30 | 33 | |
| 929 | 551M USD | 30 | 27 | |
| 929 | 207.7B USD | 30 | 18 | |
| 929 | 820M USD | 30 | 41 | |
| 929 | 354M USD | 30 | 41 | |
| 929 | 1.2B USD | 30 | 24 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score